Crossmark

Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma

Crossref DOI link: https://doi.org/10.1007/s00428-016-2041-7

Published Online: 2016-11-25

Published Print: 2017-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kendrick, Samantha

Rimsza, Lisa M

Scott, David W

Slack, Graham W

Farinha, Pedro

Tan, King L

Persky, Daniel

Puvvada, Soham

Connors, Joseph M.

Sehn, Laurie

Gascoyne, Randy D

Schmelz, Monika https://orcid.org/0000-0001-6771-4153
Funding

Funding for this research was provided by:

The Hope Foundation/SWOG Development Award 2012

Lymphoma Research Foundation (2558183)
License Information

License valid from 2016-11-25